Baird raises Taysha Gene Therapies stock price target to $12 on Rett syndrome study

1 month ago 8
Read Entire Article
  1. Homepage
  2. Finance
  3. Baird raises Taysha Gene Therapies stock price target to $12 on Rett syndrome study

Related

China property stocks surge on report of fresh stimulus measures

China property stocks surge on report of fresh stimulus meas...

17 minutes ago 0
JOYY Inc earnings beat by $0.02, revenue topped estimates

JOYY Inc earnings beat by $0.02, revenue topped estimates

17 minutes ago 0
Asia FX steady after falling on split Fed minutes; yen hits 10-mth low

Asia FX steady after falling on split Fed minutes; yen hits ...

17 minutes ago 0

Trending

1. vestas
2. catholic
3. energy
4. mckinsey
5. xiaomi
6. josh hart
7. oecd
8. benedict cumberbatch
9. us-china
10. adam sandler

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

9 months ago 606
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

8 months ago 479
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

8 months ago 326
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

10 months ago 297
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

8 months ago 283
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved